Intravenous Thrombolysis With Low-Dose Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke | Zendy

Pei Kee Loh | Zendy; Vijay K. Sharma | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intravenous Thrombolysis With Low-Dose Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Author(s) -

Pei Kee Loh,

Vijay K. Sharma

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.573113

Subject(s) - thrombolysis , medicine , recombinant tissue plasminogen activator , tissue plasminogen activator , neurology , fibrinolysis , plasminogen activator , acute stroke , fibrinolytic agent , stroke (engine) , ischemic stroke , ischemia , psychiatry , mechanical engineering , myocardial infarction , modified rankin scale , engineering

To the Editor:We read with interest the study by Toyoda et al1 regarding intravenous thrombolysis with low-dose tissue plasminogen activator (IV tPA) in Japanese patients with acute ischemic stroke (IS). We want to discuss some important issues raised by this study.Data regarding thrombolysis in Asia are scarce. Only a small proportion of patients with acute IS are thrombolyzed in Asia and the treatment approach remains largely conservative.2 Patients’ late arrival, treatment costs, and limited access to neuroimaging are some of the major contributing factors.A major concern has been the anticipated higher rates of tPA-related symptomatic intracranial …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research